RadiationOncologyNZ

@radiopeppe NEJM is there, and lancet with 3 month delay on full text . But you’re right; the others not 😥

Our hospital online library was recently updated. We no longer have access to IJROBP, R&O, NEJM, Lancet, JCO, etc. but we can now recite Julius Caesar’s DE BELLO GALLICO in Latin! Perhaps useful at GU MDM when debating surgery v. radiotherapy for localised prostate cancer 🤣🤣🤣

Come and work with us! careers.adhb.govt.nz/health-careers…

We've published our #RadiationOncology facilities report for New Zealand✍ It reveals a need to grow New Zealand’s radiation oncologist workforce and provide extra investment for cancer care equipment. Read the report👉 ow.ly/QAE950RWhr4 #RANZCR

Time to act to create a World Radiotherapy Awareness Day (week). Use the QR code or link to register your support & get involved. Spread the word to your networks. forms.office.com/r/jdexqtr2r6 WE NEED EVERYONE 🌏🌎🌍

Doctors protesting for more pay a 'moral failure', former Health NZ boss says dlvr.it/Sw22Kn

What are the patterns of lymph node failure after lung #SABR ? This Korean study at the #ESTRO23 poster session documents their experience

November is #lungcancerawarenessmonth. Did you know that #radiotherapy is an important modality in the Rx of #lungcancer but is often underutilized? @Eric73363938 @gerryhanna @ClinOncology onlinelibrary.wiley.com/doi/10.1111/re… 1/8

Radiation Oncologists who lead out campaign are fighting hard to spread the word about #radiationtherapy. We need to share what Targeting Cancer is all about. targetingcancer.com.au/what-is-radiat… @lucindamorris23 @DrewMoghanaki @TuanHatweets

New Zealand radiation therapy utilisation rates are lower than what it should be. Dr Melissa James on the Faculty Forum Panel for 2022. #targetingcancer #radiationtherapy @TargetingCancer

Some fantastic presentations at ASTRO this year! On the sheets: RTOG 1112 HCC RTOG 1005 SIB breast MSKCC prophylactic palliation RTOG 1270/ N107C central review CURB, LUSTER for NSCLC & breast oligomets EXTEND prostate oligoprog mets SCLC dose escalation LDR v HDR prostate

More resources required! @ASMSNZ @TeTokaTumai @cancer_agency

NRG/RTOG 1005 - concurrent versus sequential boost #ASTRO22 for breast #radiotherapy. Concurrent boost is non-inferior. No difference in QoL. Concordance with IMPORT High results. This patient-centric trial will save time for patients with #breastcancer. #bcsm #oncoalert

People from multiple countries around the world continue wondering if Lung SBRT is a done deal. #lcsm #radonc clinicaloncologyonline.net/article/S0936-…

I am now "special" - as are my new podcast and two associated important articles. @SalmaJabbour1 @Mat_Guc @drdavidpalma Podcast, oligomet part 1: redjournal.org/pb-assets/Heal… ESTRO/EORTC classification: redjournal.org/article/S0360-… SABR-COMET 5 yr outcomes: redjournal.org/article/S0360-…

Special issue about oligometastatic disease published by the @IJROBP 👉 THX to @sueyom and @SalmaJabbour1 for this huge effort !

I have kept this carefully for you @Ramesh_Pandey_ it is ready for you at Te Whatu Ora - te puriri o te ora. Welcome to Auckland! @DrewMoghanaki

📢 Just out! 📢 @ClinOncology #LungCancer Special Edition. Hopefully topic and timely overviews and a provocative paper on UK Lung Cancer Outcomes. 👏 thanks to all the Authors, Editorial Team, Co-Ed @HattonMQF , but huge thanks to Co-Ed @KamalThippu 🙏 for his central role

Malignant Spinal Cord Compression (MSCC)- A Thread 🧵 Old fashioned medical tools of history and clinical examination are the key Trust your instincts with this diagnosis

For those attending #ASTRO22, there’s an opportunity to reflect, revive, and reimagine just a few days later on the other side of the world. #radonc ranzcr.com/whats-on/event…